Other Species / Isoforms
  CD22 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
E78
FDGTRLYESTKDGKV
0 1
CD22 (human) FDGTRLYESTKDGKV E78
CD22 iso2 (human) FDGTRLYESTKDGKV E78
CD22 (mouse) FTGTVLYnATKTEKD N82-ng
N101
FLGDKNKNCTLSIHP
0 1
CD22 (human) FLGDKNKNCTLSIHP N101
CD22 iso2 (human) FLGDKNKNCTLSIHP N101
CD22 (mouse) FLGNRIDnCTLKIHP N111-ng
N112
SIHPVHLNDSGQLGL
0 1
CD22 (human) SIHPVHLNDSGQLGL N112
CD22 iso2 (human) SIHPVHLNDSGQLGL N112
CD22 (mouse) KIHPIRAnDSGNLGL N122-ng
G258
SDAIVREGDSVTMTC
0 1
CD22 (human) SDAIVREGDSVTMTC G258
CD22 iso2 (human) gap -
CD22 (mouse) NPTEVEKnNSVTMTC N271-ng
K288-sm
KDGTSLKkQNTFTLN
0 1
CD22 (human) KDGTSLKkQNTFTLN K288-sm
CD22 iso2 (human) gap -
CD22 (mouse) EDQELEQEQQMSKLI E309
T393
ILPWHAGTYSCVAEN
0 1
CD22 (human) ILPWHAGTYSCVAEN T393
CD22 iso2 (human) gap -
CD22 (mouse) VSPWHAGnYSCLAEN N414-ng
N445
VTLSCNYNSSNPSVT
0 1
CD22 (human) VTLSCNYNSSNPSVT N445
CD22 iso2 (human) VTLSCNYNSSNPSVT N268
CD22 (mouse) VTLVCRYnSSNPDVT N466-ng
Y591-p
AWTLEVLyAPRRLRV
0 1
CD22 (human) AWTLEVLyAPRRLRV Y591-p
CD22 iso2 (human) AWTLEVLYAPRRLRV Y414
CD22 (mouse) AWNLQVLYAPRRLRV Y612
S654
EPVKVQHSGAYWCQG
0 1
CD22 (human) EPVKVQHSGAYWCQG S654
CD22 iso2 (human) EPVKVQHSGAYWCQG S477
CD22 (mouse) EPLEVQHtGsyRCKG T675-p
A656
VKVQHSGAYWCQGTN
0 1
CD22 (human) VKVQHSGAYWCQGTN A656
CD22 iso2 (human) VKVQHSGAYWCQGTN A479
CD22 (mouse) LEVQHtGsyRCKGTN S677-p
Y657
KVQHSGAYWCQGTNS
0 1
CD22 (human) KVQHSGAYWCQGTNS Y657
CD22 iso2 (human) KVQHSGAYWCQGTNS Y480
CD22 (mouse) EVQHtGsyRCKGTNG Y678-p
T715-p
LQRRWKRtQsQQGLQ
0 1
CD22 (human) LQRRWKRtQsQQGLQ T715-p
CD22 iso2 (human) LQRRWKRTQSQQGLQ T538
CD22 (mouse) IQKKWKQNRSQQGLQ N736
S717-p
RRWKRtQsQQGLQEN
Upstream
0 2
Treatment
  • vemurafenib
CD22 (human) RRWKRtQsQQGLQEN S717-p
CD22 iso2 (human) RRWKRTQSQQGLQEN S540
CD22 (mouse) KKWKQNRSQQGLQEN S738
S725
QQGLQENSSGQSFFV
0 1
CD22 (human) QQGLQENSSGQSFFV S725
CD22 iso2 (human) QQGLQENSSGQSFFV S548
CD22 (mouse) QQGLQENssGQsFFV S746-p
S726
QGLQENSSGQSFFVR
0 2
CD22 (human) QGLQENSSGQSFFVR S726
CD22 iso2 (human) QGLQENSSGQSFFVR S549
CD22 (mouse) QGLQENssGQsFFVR S747-p
S729
QENSSGQSFFVRNKK
0 2
CD22 (human) QENSSGQSFFVRNKK S729
CD22 iso2 (human) QENSSGQSFFVRNKK S552
CD22 (mouse) QENssGQsFFVRNKK S750-p
Y752
GPHSLGCYNPMMEDG
1 0
CD22 (human) GPHSLGCYNPMMEDG Y752
CD22 iso2 (human) GPHSLGCYNPMMEDG Y575
CD22 (mouse) GPQSQGCyNPAMDDT Y773-p
Y762-p
MMEDGISyTTLRFPE
Upstream
5 1
Treatment
  • antibody
  • serum
CD22 (human) MMEDGISyTTLRFPE Y762-p
CD22 iso2 (human) MMEDGISYTTLRFPE Y585
CD22 (mouse) AMDDTVSyAILRFPE Y783-p
Y796-p
DCDDTVTySALHkRQ
3 7
CD22 (human) DCDDTVTySALHkRQ Y796-p
CD22 iso2 (human) DCDDTVTYSALHKRQ Y619
CD22 (mouse) NNSDSVTySVIQKRP Y817-p
K801-ub
VTySALHkRQVGDyE
0 1
CD22 (human) VTySALHkRQVGDyE K801-ub
CD22 iso2 (human) VTYSALHKRQVGDYE K624
CD22 (mouse) VTySVIQKRPMGDyE K822
Y807-p
HkRQVGDyENVIPDF
Upstream
Downstream
6 1
Effects on Modified Protein
  • molecular association, regulation
Phosphatases, in vitro:
  • PTP1B (human)
Putative upstream phosphatases:
  • PTP1B (human)
Treatment
  • antibody
  • serum
CD22 (human) HkRQVGDyENVIPDF Y807-p
CD22 iso2 (human) HKRQVGDYENVIPDF Y630
CD22 (mouse) QKRPMGDyENVNPSC Y828-p
Y822-p
PEDEGIHySELIQFG
Upstream
6 5
Treatment
  • antibody
  • serum
CD22 (human) PEDEGIHySELIQFG Y822-p
CD22 iso2 (human) PEDEGIHYSELIQFG Y645
CD22 (mouse) PEDESIHysELVQFG Y843-p
S823
EDEGIHySELIQFGV
0 2
CD22 (human) EDEGIHySELIQFGV S823
CD22 iso2 (human) EDEGIHYSELIQFGV S646
CD22 (mouse) EDESIHysELVQFGA S844-p
Y842-p
QAQENVDyVILKH__
Upstream
6 12
Treatment
  • antibody
  • serum
CD22 (human) QAQENVDyVILKH__ Y842-p
CD22 iso2 (human) QAQENVDYVILKH__ Y665
CD22 (mouse) QAKEDVDyVTLKH__ Y863-p